EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitFallberichtOpen Access · CC BY 4.0

The Approach of Artificial Intelligence in Neuroendocrine Carcinomas of the Breast: A Next Step towards Precision Pathology?—A Case Report and Review of the Literature

Diana Maria Chiorean iD, Melinda-Ildiko Mitranovici iD, Maria Cezara Mureșan, Corneliu-Florin Buicu iD, Raluca Moraru, Liviu Moraru, Titiana Cornelia Cotoi, Ovidiu Simion Cotoi, Adrian Apostol, Sabin Gligore Turdean iD, Claudiu Mărginean, Ion Petre und 5 weitere

Medicina · 2023

DOI: 10.3390/medicina59040672 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Medicina, 2023. Verfasst von Diana Maria Chiorean und 16 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, County Clinical Hospital of Targu Mures, 540072 Targu Mures, Romania. Hauptthemen laut MEDLINE: Carcinoma, Neuroendocrine, Neuroendocrine Tumors, Breast Neoplasms. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Primary neuroendocrine tumors (NETs) of the breast are considered a rare and undervalued subtype of breast carcinoma that occur mainly in postmenopausal women and are graded as G1 or G2 NETs or an invasive neuroendocrine carcinoma (NEC) (small cell or large cell). To establish a final diagnosis of breast carcinoma with neuroendocrine differentiation, it is essential to perform an immunohistochemical profile of the tumor, using antibodies against synaptophysin or chromogranin, as well as the MIB-1 proliferation index, one of the most controversial markers in breast pathology regarding its methodology in current clinical practice. A standardization error between institutions and pathologists regarding the evaluation of the MIB-1 proliferation index is present. Another challenge refers to the counting process of MIB-1′s expressiveness, which is known as a time-consuming process. The involvement of AI (artificial intelligence) automated systems could be a solution for diagnosing early stages, as well. We present the case of a post-menopausal 79-year-old woman diagnosed with primary neuroendocrine carcinoma of the breast (NECB). The purpose of this paper is to expose the interpretation of MIB-1 expression in our patient’ s case of breast neuroendocrine carcinoma, assisted by artificial intelligence (AI) software (HALO—IndicaLabs), and to analyze the associations between MIB-1 and common histopathological parameters.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Carcinoma, NeuroendocrineNeuroendocrine TumorsBreast NeoplasmsHumansFemaleAgedArtificial IntelligenceBreast

Stichwörter der Autor:innen

breast neuroendocrine tumors (NETs)deep learningearly breast carcinomaexplainable artificial intelligence (AI)histopathologypattern recognitionwhole slide image (WSI)

Autor:innen und Institutionen

  • Department of Pathology, County Clinical Hospital of Targu Mures, 540072 Targu Mures, Romania.
  • Department of Obstetrics and Gynecology, Emergency County Hospital Hunedoara, 14 Victoriei Street, 331057 Hunedoara, Romania.
  • Department of Obstetrics and Gynecology, "Victor Babes" University of Medicine and Pharmacy, 2 Eftimie Murgu Sq., 300041 Timisoara, Romania.
  • Public Health and Management Department, "George Emil Palade" University of Medicine, Pharmacy, Science and Technology of Targu Mures, 540139 Targu Mures, Romania.
  • Faculty of Medicine, "George Emil Palade" University of Medicine, Pharmacy, Sciences and Technology, 540142 Targu Mures, Romania.
  • Department of Anatomy, "George Emil Palade" University of Medicine, Pharmacy, Sciences and Technology, 540142 Targu Mures, Romania.

ORCID-Profile: Diana Maria Chiorean, Melinda-Ildiko Mitranovici, Corneliu-Florin Buicu, Sabin Gligore Turdean, Zsuzsanna Simon-Szabo, Viviana Ivan, Havva Serap Toru

Zitieren

APA

Chiorean, D. M., Mitranovici, M. I., Mureșan, M. C., Buicu, C. F., Moraru, R., Moraru, L., Cotoi, T. C., Cotoi, O. S., Apostol, A., Turdean, S. G., Mărginean, C., Petre, I., Oală, I. E., Simon-Szabo, Z., Ivan, V., Roșca, A. N., & Toru, H. S. (2023). The Approach of Artificial Intelligence in Neuroendocrine Carcinomas of the Breast: A Next Step towards Precision Pathology?—A Case Report and Review of the Literature. Medicina. https://doi.org/10.3390/medicina59040672

Vancouver

Chiorean DM, Mitranovici MI, Mureșan MC, Buicu CF, Moraru R, Moraru L, et al. The Approach of Artificial Intelligence in Neuroendocrine Carcinomas of the Breast: A Next Step towards Precision Pathology?—A Case Report and Review of the Literature. Medicina. 2023. doi:10.3390/medicina59040672

BibTeX
@article{Chiorean2023,
  author = {Chiorean, Diana Maria and Mitranovici, Melinda-Ildiko and Mureșan, Maria Cezara and Buicu, Corneliu-Florin and Moraru, Raluca and Moraru, Liviu and Cotoi, Titiana Cornelia and Cotoi, Ovidiu Simion and Apostol, Adrian and Turdean, Sabin Gligore and Mărginean, Claudiu and Petre, Ion and Oală, Ioan Emilian and Simon-Szabo, Zsuzsanna and Ivan, Viviana and Roșca, Ancuța Noela and Toru, Havva Serap},
  title = {The Approach of Artificial Intelligence in Neuroendocrine Carcinomas of the Breast: A Next Step towards Precision Pathology?—A Case Report and Review of the Literature},
  journal = {Medicina},
  year = {2023},
  doi = {10.3390/medicina59040672}
}
Kostenlos starten →